SEC Tracker
Get the app

Corcept Therapeutics CORT

Corcept Therapeutics: reports quarterly results and makes a Regulation FD disclosure

Form
8-K
Filed
Period
Importance
Major
Document
8-K
Exhibit 99.1
Press release
  • Reports quarterly results (2.02)
  • Makes a Regulation FD disclosure (7.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Corcept Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2834) and public float over $2B, nearest public float first, as each company reports it on its annual report cover.

  1. Jazz Pharmaceuticals JAZZ public float $6.3B, Jun 30, 2025
  2. Madrigal Pharmaceuticals MDGL public float $5.6B, Jun 30, 2025
  3. Biomarin Pharmaceutical BMRN public float $6.7B, Jun 30, 2025
  4. Ionis Pharmaceuticals IONS public float $5.3B, Jun 30, 2025
  5. Prestige Consumer Healthcare PBH public float $3.0B, Sep 30, 2025